| UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
|||||||
|
Fusion Protein:HDAC7-ACSS3 |
Fusion Protein Summary |
 Fusion gene summary |
| Fusion partner gene information | Fusion gene name: HDAC7-ACSS3 | FusionPDB ID: 35856 | FusionGDB2.0 ID: 35856 | Hgene | Tgene | Gene symbol | HDAC7 | ACSS3 | Gene ID | 51564 | 79611 |
| Gene name | histone deacetylase 7 | acyl-CoA synthetase short chain family member 3 | |
| Synonyms | HD7|HD7A|HDAC7A | - | |
| Cytomap | 12q13.11 | 12q21.31 | |
| Type of gene | protein-coding | protein-coding | |
| Description | histone deacetylase 7histone deacetylase 7A | acyl-CoA synthetase short-chain family member 3, mitochondrialAMP-binding enzyme, 33217acetate--CoA ligase 3propionate--CoA ligase | |
| Modification date | 20200327 | 20200313 | |
| UniProtAcc | Q8WUI4 | Q9H6R3 | |
| Ensembl transtripts involved in fusion gene | ENST ids | ENST00000080059, ENST00000354334, ENST00000552960, ENST00000380610, ENST00000427332, ENST00000488927, | ENST00000548324, ENST00000261206, ENST00000548058, |
| Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 11 X 8 X 6=528 | 15 X 11 X 7=1155 |
| # samples | 15 | 12 | |
| ** MAII score | log2(15/528*10)=-1.81557542886257 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(12/1155*10)=-3.2667865406949 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context (manual curation of fusion genes in FusionPDB) | PubMed: HDAC7 [Title/Abstract] AND ACSS3 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | HDAC7(48213550)-ACSS3(81528595), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | HDAC7-ACSS3 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. HDAC7-ACSS3 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. HDAC7-ACSS3 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. HDAC7-ACSS3 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | HDAC7 | GO:0032703 | negative regulation of interleukin-2 production | 17360565 |
| Fusion gene breakpoints across HDAC7 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across ACSS3 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
Top |
Fusion Gene Sample Information |
| Fusion gene information from FusionGDB2.0. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | SARC | TCGA-DX-A7EI-01A | HDAC7 | chr12 | 48213550 | - | ACSS3 | chr12 | 81528595 | + |
Top |
Fusion ORF Analysis |
| Fusion information from ORFfinder translation from full-length transcript sequence from FusionPDB. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000080059 | HDAC7 | chr12 | 48213550 | - | ENST00000548058 | ACSS3 | chr12 | 81528595 | + | 3456 | 19 | 16 | 1623 | 535 |
| ENST00000080059 | HDAC7 | chr12 | 48213550 | - | ENST00000261206 | ACSS3 | chr12 | 81528595 | + | 2168 | 19 | 16 | 1623 | 535 |
| ENST00000354334 | HDAC7 | chr12 | 48213550 | - | ENST00000548058 | ACSS3 | chr12 | 81528595 | + | 3537 | 100 | 61 | 1704 | 547 |
| ENST00000354334 | HDAC7 | chr12 | 48213550 | - | ENST00000261206 | ACSS3 | chr12 | 81528595 | + | 2249 | 100 | 61 | 1704 | 547 |
| ENST00000552960 | HDAC7 | chr12 | 48213550 | - | ENST00000548058 | ACSS3 | chr12 | 81528595 | + | 3557 | 120 | 81 | 1724 | 547 |
| ENST00000552960 | HDAC7 | chr12 | 48213550 | - | ENST00000261206 | ACSS3 | chr12 | 81528595 | + | 2269 | 120 | 81 | 1724 | 547 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000080059 | ENST00000548058 | HDAC7 | chr12 | 48213550 | - | ACSS3 | chr12 | 81528595 | + | 0.000366408 | 0.99963355 |
| ENST00000080059 | ENST00000261206 | HDAC7 | chr12 | 48213550 | - | ACSS3 | chr12 | 81528595 | + | 0.000333123 | 0.9996669 |
| ENST00000354334 | ENST00000548058 | HDAC7 | chr12 | 48213550 | - | ACSS3 | chr12 | 81528595 | + | 0.000357719 | 0.99964225 |
| ENST00000354334 | ENST00000261206 | HDAC7 | chr12 | 48213550 | - | ACSS3 | chr12 | 81528595 | + | 0.000324187 | 0.99967587 |
| ENST00000552960 | ENST00000548058 | HDAC7 | chr12 | 48213550 | - | ACSS3 | chr12 | 81528595 | + | 0.000364026 | 0.99963593 |
| ENST00000552960 | ENST00000261206 | HDAC7 | chr12 | 48213550 | - | ACSS3 | chr12 | 81528595 | + | 0.000338851 | 0.9996612 |
Top |
Fusion Amino Acid Sequences |
| For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >35856_35856_1_HDAC7-ACSS3_HDAC7_chr12_48213550_ENST00000080059_ACSS3_chr12_81528595_ENST00000261206_length(amino acids)=535AA_BP=1 MVSKLAGVLVKHGIKKGDTVVIYMPMIPQAMYTMLACARIGAIHSLIFGGFASKELSSRIDHVKPKVVVTASFGIEPGRRVEYVPLVEEA LKIGQHKPDKILIYNRPNMEAVPLAPGRDLDWDEEMAKAQSHDCVPVLSEHPLYILYTSGTTGLPKGVIRPTGGYAVMLHWSMSSIYGLQ PGEVWWAASDLGWVVGHSYICYGPLLHGNTTVLYEGKPVGTPDAGAYFRVLAEHGVAALFTAPTAIRAIRQQDPGAALGKQYSLTRFKTL FVAGERCDVETLEWSKNVFRVPVLDHWWQTETGSPITASCVGLGNSKTPPPGQAGKSVPGYNVMILDDNMQKLKARCLGNIVVKLPLPPG AFSGLWKNQEAFKHLYFEKFPGYYDTMDAGYMDEEGYLYVMSRVDDVINVAGHRISAGAIEESILSHGTVADCAVVGKEDPLKGHVPLAL -------------------------------------------------------------- >35856_35856_2_HDAC7-ACSS3_HDAC7_chr12_48213550_ENST00000080059_ACSS3_chr12_81528595_ENST00000548058_length(amino acids)=535AA_BP=1 MVSKLAGVLVKHGIKKGDTVVIYMPMIPQAMYTMLACARIGAIHSLIFGGFASKELSSRIDHVKPKVVVTASFGIEPGRRVEYVPLVEEA LKIGQHKPDKILIYNRPNMEAVPLAPGRDLDWDEEMAKAQSHDCVPVLSEHPLYILYTSGTTGLPKGVIRPTGGYAVMLHWSMSSIYGLQ PGEVWWAASDLGWVVGHSYICYGPLLHGNTTVLYEGKPVGTPDAGAYFRVLAEHGVAALFTAPTAIRAIRQQDPGAALGKQYSLTRFKTL FVAGERCDVETLEWSKNVFRVPVLDHWWQTETGSPITASCVGLGNSKTPPPGQAGKSVPGYNVMILDDNMQKLKARCLGNIVVKLPLPPG AFSGLWKNQEAFKHLYFEKFPGYYDTMDAGYMDEEGYLYVMSRVDDVINVAGHRISAGAIEESILSHGTVADCAVVGKEDPLKGHVPLAL -------------------------------------------------------------- >35856_35856_3_HDAC7-ACSS3_HDAC7_chr12_48213550_ENST00000354334_ACSS3_chr12_81528595_ENST00000261206_length(amino acids)=547AA_BP=11 MRAPAPGCTAPALVSKLAGVLVKHGIKKGDTVVIYMPMIPQAMYTMLACARIGAIHSLIFGGFASKELSSRIDHVKPKVVVTASFGIEPG RRVEYVPLVEEALKIGQHKPDKILIYNRPNMEAVPLAPGRDLDWDEEMAKAQSHDCVPVLSEHPLYILYTSGTTGLPKGVIRPTGGYAVM LHWSMSSIYGLQPGEVWWAASDLGWVVGHSYICYGPLLHGNTTVLYEGKPVGTPDAGAYFRVLAEHGVAALFTAPTAIRAIRQQDPGAAL GKQYSLTRFKTLFVAGERCDVETLEWSKNVFRVPVLDHWWQTETGSPITASCVGLGNSKTPPPGQAGKSVPGYNVMILDDNMQKLKARCL GNIVVKLPLPPGAFSGLWKNQEAFKHLYFEKFPGYYDTMDAGYMDEEGYLYVMSRVDDVINVAGHRISAGAIEESILSHGTVADCAVVGK EDPLKGHVPLALCVLRKDINATEEQVLEEIVKHVRQNIGPVAAFRNAVFVKQLPKTRSGKIPRSALSAIVNGKPYKITSTIEDPSIFGHV -------------------------------------------------------------- >35856_35856_4_HDAC7-ACSS3_HDAC7_chr12_48213550_ENST00000354334_ACSS3_chr12_81528595_ENST00000548058_length(amino acids)=547AA_BP=11 MRAPAPGCTAPALVSKLAGVLVKHGIKKGDTVVIYMPMIPQAMYTMLACARIGAIHSLIFGGFASKELSSRIDHVKPKVVVTASFGIEPG RRVEYVPLVEEALKIGQHKPDKILIYNRPNMEAVPLAPGRDLDWDEEMAKAQSHDCVPVLSEHPLYILYTSGTTGLPKGVIRPTGGYAVM LHWSMSSIYGLQPGEVWWAASDLGWVVGHSYICYGPLLHGNTTVLYEGKPVGTPDAGAYFRVLAEHGVAALFTAPTAIRAIRQQDPGAAL GKQYSLTRFKTLFVAGERCDVETLEWSKNVFRVPVLDHWWQTETGSPITASCVGLGNSKTPPPGQAGKSVPGYNVMILDDNMQKLKARCL GNIVVKLPLPPGAFSGLWKNQEAFKHLYFEKFPGYYDTMDAGYMDEEGYLYVMSRVDDVINVAGHRISAGAIEESILSHGTVADCAVVGK EDPLKGHVPLALCVLRKDINATEEQVLEEIVKHVRQNIGPVAAFRNAVFVKQLPKTRSGKIPRSALSAIVNGKPYKITSTIEDPSIFGHV -------------------------------------------------------------- >35856_35856_5_HDAC7-ACSS3_HDAC7_chr12_48213550_ENST00000552960_ACSS3_chr12_81528595_ENST00000261206_length(amino acids)=547AA_BP=11 MRAPAPGCTAPALVSKLAGVLVKHGIKKGDTVVIYMPMIPQAMYTMLACARIGAIHSLIFGGFASKELSSRIDHVKPKVVVTASFGIEPG RRVEYVPLVEEALKIGQHKPDKILIYNRPNMEAVPLAPGRDLDWDEEMAKAQSHDCVPVLSEHPLYILYTSGTTGLPKGVIRPTGGYAVM LHWSMSSIYGLQPGEVWWAASDLGWVVGHSYICYGPLLHGNTTVLYEGKPVGTPDAGAYFRVLAEHGVAALFTAPTAIRAIRQQDPGAAL GKQYSLTRFKTLFVAGERCDVETLEWSKNVFRVPVLDHWWQTETGSPITASCVGLGNSKTPPPGQAGKSVPGYNVMILDDNMQKLKARCL GNIVVKLPLPPGAFSGLWKNQEAFKHLYFEKFPGYYDTMDAGYMDEEGYLYVMSRVDDVINVAGHRISAGAIEESILSHGTVADCAVVGK EDPLKGHVPLALCVLRKDINATEEQVLEEIVKHVRQNIGPVAAFRNAVFVKQLPKTRSGKIPRSALSAIVNGKPYKITSTIEDPSIFGHV -------------------------------------------------------------- >35856_35856_6_HDAC7-ACSS3_HDAC7_chr12_48213550_ENST00000552960_ACSS3_chr12_81528595_ENST00000548058_length(amino acids)=547AA_BP=11 MRAPAPGCTAPALVSKLAGVLVKHGIKKGDTVVIYMPMIPQAMYTMLACARIGAIHSLIFGGFASKELSSRIDHVKPKVVVTASFGIEPG RRVEYVPLVEEALKIGQHKPDKILIYNRPNMEAVPLAPGRDLDWDEEMAKAQSHDCVPVLSEHPLYILYTSGTTGLPKGVIRPTGGYAVM LHWSMSSIYGLQPGEVWWAASDLGWVVGHSYICYGPLLHGNTTVLYEGKPVGTPDAGAYFRVLAEHGVAALFTAPTAIRAIRQQDPGAAL GKQYSLTRFKTLFVAGERCDVETLEWSKNVFRVPVLDHWWQTETGSPITASCVGLGNSKTPPPGQAGKSVPGYNVMILDDNMQKLKARCL GNIVVKLPLPPGAFSGLWKNQEAFKHLYFEKFPGYYDTMDAGYMDEEGYLYVMSRVDDVINVAGHRISAGAIEESILSHGTVADCAVVGK EDPLKGHVPLALCVLRKDINATEEQVLEEIVKHVRQNIGPVAAFRNAVFVKQLPKTRSGKIPRSALSAIVNGKPYKITSTIEDPSIFGHV -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr12:48213550/chr12:81528595) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| HDAC7 | ACSS3 |
| FUNCTION: Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein complexes. Involved in muscle maturation by repressing transcription of myocyte enhancer factors such as MEF2A, MEF2B and MEF2C. During muscle differentiation, it shuttles into the cytoplasm, allowing the expression of myocyte enhancer factors (By similarity). May be involved in Epstein-Barr virus (EBV) latency, possibly by repressing the viral BZLF1 gene. Positively regulates the transcriptional repressor activity of FOXP3 (PubMed:17360565). Serves as a corepressor of RARA, causing its deacetylation and inhibition of RARE DNA element binding (PubMed:28167758). In association with RARA, plays a role in the repression of microRNA-10a and thereby in the inflammatory response (PubMed:28167758). {ECO:0000250|UniProtKB:Q8C2B3, ECO:0000269|PubMed:12239305, ECO:0000269|PubMed:17360565, ECO:0000269|PubMed:28167758}. | FUNCTION: Catalyzes the synthesis of acetyl-CoA from short-chain fatty acids (PubMed:28003429). Propionate is the preferred substrate (PubMed:28003429). Can utilize acetate and butyrate with a much lower affinity (By similarity). {ECO:0000250|UniProtKB:A0A0G2K047, ECO:0000269|PubMed:28003429}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - Retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | ACSS3 | chr12:48213550 | chr12:81528595 | ENST00000548058 | 1 | 16 | 425_427 | 152.0 | 687.0 | Nucleotide binding | ATP | |
| Tgene | ACSS3 | chr12:48213550 | chr12:81528595 | ENST00000548058 | 1 | 16 | 446_451 | 152.0 | 687.0 | Nucleotide binding | ATP | |
| Tgene | ACSS3 | chr12:48213550 | chr12:81528595 | ENST00000548324 | 0 | 11 | 425_427 | 0 | 369.0 | Nucleotide binding | ATP | |
| Tgene | ACSS3 | chr12:48213550 | chr12:81528595 | ENST00000548324 | 0 | 11 | 446_451 | 0 | 369.0 | Nucleotide binding | ATP | |
| Tgene | ACSS3 | chr12:48213550 | chr12:81528595 | ENST00000548058 | 1 | 16 | 227_230 | 152.0 | 687.0 | Region | Coenzyme A binding | |
| Tgene | ACSS3 | chr12:48213550 | chr12:81528595 | ENST00000548324 | 0 | 11 | 227_230 | 0 | 369.0 | Region | Coenzyme A binding |
| - Not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | HDAC7 | chr12:48213550 | chr12:81528595 | ENST00000080059 | - | 1 | 26 | 197_203 | 6.333333333333333 | 992.0 | Compositional bias | Note=Poly-Ser |
| Hgene | HDAC7 | chr12:48213550 | chr12:81528595 | ENST00000080059 | - | 1 | 26 | 368_373 | 6.333333333333333 | 992.0 | Compositional bias | Note=Poly-Pro |
| Hgene | HDAC7 | chr12:48213550 | chr12:81528595 | ENST00000354334 | - | 1 | 25 | 197_203 | 6.333333333333333 | 955.0 | Compositional bias | Note=Poly-Ser |
| Hgene | HDAC7 | chr12:48213550 | chr12:81528595 | ENST00000354334 | - | 1 | 25 | 368_373 | 6.333333333333333 | 955.0 | Compositional bias | Note=Poly-Pro |
| Hgene | HDAC7 | chr12:48213550 | chr12:81528595 | ENST00000427332 | - | 1 | 26 | 197_203 | 0 | 953.0 | Compositional bias | Note=Poly-Ser |
| Hgene | HDAC7 | chr12:48213550 | chr12:81528595 | ENST00000427332 | - | 1 | 26 | 368_373 | 0 | 953.0 | Compositional bias | Note=Poly-Pro |
| Hgene | HDAC7 | chr12:48213550 | chr12:81528595 | ENST00000552960 | - | 1 | 25 | 197_203 | 6.333333333333333 | 975.0 | Compositional bias | Note=Poly-Ser |
| Hgene | HDAC7 | chr12:48213550 | chr12:81528595 | ENST00000552960 | - | 1 | 25 | 368_373 | 6.333333333333333 | 975.0 | Compositional bias | Note=Poly-Pro |
| Hgene | HDAC7 | chr12:48213550 | chr12:81528595 | ENST00000080059 | - | 1 | 26 | 918_952 | 6.333333333333333 | 992.0 | Motif | Nuclear export signal |
| Hgene | HDAC7 | chr12:48213550 | chr12:81528595 | ENST00000354334 | - | 1 | 25 | 918_952 | 6.333333333333333 | 955.0 | Motif | Nuclear export signal |
| Hgene | HDAC7 | chr12:48213550 | chr12:81528595 | ENST00000427332 | - | 1 | 26 | 918_952 | 0 | 953.0 | Motif | Nuclear export signal |
| Hgene | HDAC7 | chr12:48213550 | chr12:81528595 | ENST00000552960 | - | 1 | 25 | 918_952 | 6.333333333333333 | 975.0 | Motif | Nuclear export signal |
| Hgene | HDAC7 | chr12:48213550 | chr12:81528595 | ENST00000080059 | - | 1 | 26 | 1_268 | 6.333333333333333 | 992.0 | Region | Transcription repression 1 |
| Hgene | HDAC7 | chr12:48213550 | chr12:81528595 | ENST00000080059 | - | 1 | 26 | 218_546 | 6.333333333333333 | 992.0 | Region | Transcription repression 2 |
| Hgene | HDAC7 | chr12:48213550 | chr12:81528595 | ENST00000080059 | - | 1 | 26 | 518_865 | 6.333333333333333 | 992.0 | Region | Note=Histone deacetylase |
| Hgene | HDAC7 | chr12:48213550 | chr12:81528595 | ENST00000354334 | - | 1 | 25 | 1_268 | 6.333333333333333 | 955.0 | Region | Transcription repression 1 |
| Hgene | HDAC7 | chr12:48213550 | chr12:81528595 | ENST00000354334 | - | 1 | 25 | 218_546 | 6.333333333333333 | 955.0 | Region | Transcription repression 2 |
| Hgene | HDAC7 | chr12:48213550 | chr12:81528595 | ENST00000354334 | - | 1 | 25 | 518_865 | 6.333333333333333 | 955.0 | Region | Note=Histone deacetylase |
| Hgene | HDAC7 | chr12:48213550 | chr12:81528595 | ENST00000427332 | - | 1 | 26 | 1_268 | 0 | 953.0 | Region | Transcription repression 1 |
| Hgene | HDAC7 | chr12:48213550 | chr12:81528595 | ENST00000427332 | - | 1 | 26 | 218_546 | 0 | 953.0 | Region | Transcription repression 2 |
| Hgene | HDAC7 | chr12:48213550 | chr12:81528595 | ENST00000427332 | - | 1 | 26 | 518_865 | 0 | 953.0 | Region | Note=Histone deacetylase |
| Hgene | HDAC7 | chr12:48213550 | chr12:81528595 | ENST00000552960 | - | 1 | 25 | 1_268 | 6.333333333333333 | 975.0 | Region | Transcription repression 1 |
| Hgene | HDAC7 | chr12:48213550 | chr12:81528595 | ENST00000552960 | - | 1 | 25 | 218_546 | 6.333333333333333 | 975.0 | Region | Transcription repression 2 |
| Hgene | HDAC7 | chr12:48213550 | chr12:81528595 | ENST00000552960 | - | 1 | 25 | 518_865 | 6.333333333333333 | 975.0 | Region | Note=Histone deacetylase |
Top |
Fusion Protein-Protein Interaction |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type from validated records (BIOGRID-3.4.160) |
| Gene | PPI interactors |
| Protein-protein interactors based on sequence similarity (STRING) |
| Gene | STRING network |
| HDAC7 | |
| ACSS3 |
| - Retained interactions in fusion protein (protein functional feature from UniProt). |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost interactions due to fusion (protein functional feature from UniProt). |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| Hgene | HDAC7 | chr12:48213550 | chr12:81528595 | ENST00000080059 | - | 1 | 26 | 49_149 | 6.333333333333333 | 992.0 | MEF2A |
| Hgene | HDAC7 | chr12:48213550 | chr12:81528595 | ENST00000354334 | - | 1 | 25 | 49_149 | 6.333333333333333 | 955.0 | MEF2A |
| Hgene | HDAC7 | chr12:48213550 | chr12:81528595 | ENST00000427332 | - | 1 | 26 | 49_149 | 0 | 953.0 | MEF2A |
| Hgene | HDAC7 | chr12:48213550 | chr12:81528595 | ENST00000552960 | - | 1 | 25 | 49_149 | 6.333333333333333 | 975.0 | MEF2A |
| Hgene | HDAC7 | chr12:48213550 | chr12:81528595 | ENST00000080059 | - | 1 | 26 | 1_98 | 6.333333333333333 | 992.0 | MEF2C |
| Hgene | HDAC7 | chr12:48213550 | chr12:81528595 | ENST00000354334 | - | 1 | 25 | 1_98 | 6.333333333333333 | 955.0 | MEF2C |
| Hgene | HDAC7 | chr12:48213550 | chr12:81528595 | ENST00000427332 | - | 1 | 26 | 1_98 | 0 | 953.0 | MEF2C |
| Hgene | HDAC7 | chr12:48213550 | chr12:81528595 | ENST00000552960 | - | 1 | 25 | 1_98 | 6.333333333333333 | 975.0 | MEF2C |
| Hgene | HDAC7 | chr12:48213550 | chr12:81528595 | ENST00000080059 | - | 1 | 26 | 877_952 | 6.333333333333333 | 992.0 | SIN3A |
| Hgene | HDAC7 | chr12:48213550 | chr12:81528595 | ENST00000354334 | - | 1 | 25 | 877_952 | 6.333333333333333 | 955.0 | SIN3A |
| Hgene | HDAC7 | chr12:48213550 | chr12:81528595 | ENST00000427332 | - | 1 | 26 | 877_952 | 0 | 953.0 | SIN3A |
| Hgene | HDAC7 | chr12:48213550 | chr12:81528595 | ENST00000552960 | - | 1 | 25 | 877_952 | 6.333333333333333 | 975.0 | SIN3A |
Top |
Related Drugs to HDAC7-ACSS3 |
| Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
| Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to HDAC7-ACSS3 |
| Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
| Hgene | Tgene | Disease | Source | PMID |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies